Download
s00415-021-10661-z.pdf 457,47KB
WeightNameValue
1000 Titel
  • CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
1000 Autor/in
  1. Kogel, Ann-Kathrin |
  2. Gold, Ralf |
  3. Schneider, Ruth |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-06-27
1000 Erschienen in
1000 Quellenangabe
  • 268(11):4374-4375
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00415-021-10661-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505348/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Adult-onset ataxias are a genetically and clinically heterogeneous group of movement disorders. In addition to nuclear gene mutations, sequence changes have also been described in the mitochondrial genome. Here, we present findings of mutation analysis of the mitochondrial gene MT-ATP6. We analyzed 94 patients with adult-onset spinocerebellar ataxia (SCA), including 34 sporadic cases. In all patients, common sequence changes found in SCAs such as repeat expansions and point mutations had been excluded previously. We found pathogenic MT-ATP variants in five of these patients (5.32%), two of whom were sporadic. Four of the five mutations have not previously been described in ataxias. All but one of these mutations affect transmembrane helices of subunit-α of ATP synthase. Two mutations (p.G16S, and p.P18S) disrupt transmembrane helix 1 (TMH1), one mutation (p.G167D) affects TMH5, and another one (p.L217P) TMH6. The fifth mutation (p.T96A) describes an amino acid change in close proximity to transmembrane helix 3 (TMH3). The level of heteroplasmy was either complete or very high ranging from 87 to 99%. The high prevalence of pathogenic MT-ATP6 variants suggests that analysis of this gene should be included in the routine workup of both hereditary and sporadic ataxias.
1000 Sacherschließung
lokal Dimethyl Fumarate/adverse effects [MeSH]
lokal Neurology
lokal Multiple Sclerosis, Relapsing-Remitting/drug therapy [MeSH]
lokal Humans [MeSH]
lokal Letter to the Editors
lokal Cytomegalovirus Infections/complications [MeSH]
lokal Multiple Sclerosis/drug therapy [MeSH]
lokal Lymphopenia/chemically induced [MeSH]
lokal Neuroradiology
lokal Neurosciences
lokal Immunosuppressive Agents/adverse effects [MeSH]
lokal Meningitis [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-8217-6063|https://frl.publisso.de/adhoc/uri/R29sZCwgUmFsZg==|https://frl.publisso.de/adhoc/uri/U2NobmVpZGVyLCBSdXRo
1000 Hinweis
  • DeepGreen-ID: 056b83ed1b604f4f8a3170fe5f34e864 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450236.rdf
1000 Erstellt am 2023-05-09T11:40:37.068+0200
1000 Erstellt von 322
1000 beschreibt frl:6450236
1000 Zuletzt bearbeitet 2023-10-14T00:46:55.938+0200
1000 Objekt bearb. Sat Oct 14 00:46:55 CEST 2023
1000 Vgl. frl:6450236
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450236 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source